RedHill Biopharma Profile

USD 0.00  0.00%

RedHill Biopharma Summary

RedHill Biopharma Ltd (REDIF) is traded on OTC Market in USA. It is located in Tel Aviv, and employs 12 people. The company currently falls under 'Small-Cap' category with current market capitalization of 155.39 M. RedHill Biopharma Ltd has 170.07 M outstanding shares. REDHILL BIOPHARMA has accumulated about 40.5 M in cash with (24.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Check RedHill Biopharma Probability Of Bankruptcy

Key Fundamentals

RedHill Biopharma Against Markets

Current Ratings

RedHill Biopharma 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for RedHill Biopharma Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
RedHill Biopharma Ltd., a biopharmaceutical company, primarily focuses on the development and commercialization of late clinicalstage, proprietary, orallyadministered, small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, and cancer. more
NameRedHill Biopharma Ltd
CEOOri ShiloView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressTel Aviv,
ExchangeOTC Market
Phone972 3 541 3131
CurrencyUSD - US Dollar

Current Sentiment - REDIF

RedHill Biopharma Investor Sentiment
Macroaxis portfolio users are evenly split in their perspective on investing in RedHill Biopharma Ltd. What is your perspective on investing in RedHill Biopharma Ltd? Are you bullish or bearish?
50% Bullish
50% Bearish


RedHill Biopharma Corporate Directors
Ofer Tsimchi Director
Shmuel Cabilly Director
Kenneth Reed Director
Additionally take a look at Your Equity Center. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.